Podcast: Play in new window | Download
The Big Ones
SoftBank COO Marcelo Claure revealed on Thursday that it has committed a total of $18.5bn in debt and equity financing to WeWork owner We Company. It comes after SoftBank, on Tuesday, confirmed details of a $9.5bn rescue package for We Company that includes a $3bn tender offer which will allow earlier investors including Jin Jiang International and Legend Holdings to exit, albeit at a sizeable loss. SoftBank will emerge with an 80% stake in a streamlined company while We Co will come out with enough capital to sustain itself for the time being, hopefully.
Happier times for Databricks, the UC Berkeley spinout that has built a data preparation platform tailored for work with advanced analytics tools. It’s secured $400m in a Microsoft-backed series F round that boosted its valuation from $2.75bn to $6.2bn in just eight months.
Total has launched a $400m investment unit called Total Carbon Neutrality Ventures that looks as if it is assuming the mantle of the petroleum supplier’s main corporate venturing vehicle. The capital is intended to be allocated over the next five years and will fund developers of technologies in areas like energy storage, smart energy and mobility.
On GUV, Oxford Nanopore, the UK-based genetic sequencing technology spinout of University of Oxford, is reportedly seeking £1.6bn ($2.1bn) in a forthcoming private placement. The purported transaction could help Woodford Investment Management, soon to close having failed to restore its liquidity, by enabling the firm to sell down equity that reportedly represents the biggest stake in its portfolio by market value. It is unclear how the move tallies with earlier suggestions that the spinout was looking to go public.
Speaking of Woodford, good news for the spinout-focused Patient Capital Trust. Asset management firm Schroders has rescued trust and agreed terms for the switch to take place before the end of 2019, when it will be renamed Schroder UK Public Private Trust. Schroders will waive its management fee for the first three months and will then charge 0.8% or 1% annually depending on the size of each client’s investment.
Taimei Technology, which provides clinical trials software that helps multiple stakeholders in the process interact with each other, and ¨has confirmed $212m in funding across two rounds. One of those is a $132m series E-plus round led by Tencent, which added to an $80m series E featuring SoftBank China Venture Capital, some details of which originally emerged in January.
Elsewhere in China, global positioning technology provider Qianxun Spatial Intelligence has secured $141m in series A funding, four years after it was co-founded by Alibaba and Norinco Group. The cash was reportedly raised at a $1.84bn valuation and the round was co-led by government-owned vehicles Shanghai International Group, Industrial and Commercial Bank of China and China State-Owned Capital Venture Investment Fund.
Security and surveillance technology provider Hikvision is putting together its own investment fund, Hikvision Smart Industry Investment Fund, which will be equipped with some $141m in capital.
Aerospace and defence equipment manufacturer Safran launched corporate venturing unit Safran Corporate Ventures in 2015 and, after allocating most of its original capital, has added another $33.5m to take its total budget to about $89m. The fund has invested in 10 companies, one of which has so far heralded an exit, and the capital is expected to be spent over the next two years.
Partners Healthcare has run corporate venturing unit Partners Innovation Fund since 2008 but has elected to also provide $80m for two specialist funds. The care system operator will put $50m into a vehicle known as Translational Innovation Fund, which will support development of preclinical drugs based on research at its hospitals, while $30m is going to Artificial Intelligence and Digital Translation Fund, which will work on innovative digital technologies with Partners Healthcare’s vendors.
Bloomberg Beta has meanwhile launched its third $75m fund in six years, with the cash again coming solely from Bloomberg. The firm is sponsored by Bloomberg but operates separately, with a focus on ‘the future of work’ and has built up a portfolio that includes unicorns Knotel and Flexport as well as the likes of Masterclass, AppZen, Rigetti Computing and InfluxData, which each look well on their way to that status.
And Yissum, the tech transfer company of Hebrew University of Jerusalem (HUJ), has joined forces with drug discovery firm Evotec to launch Lab555, the latest iteration of the latter’s academic commercialisation bridge model.
More waves in the IPO space, with Singapore-based online real estate marketplace PropertyGuru pulling out of an offering in Australia that would have raised $257m had the company floated at the top of its range. Media conglomerate Emtek had been looking to sell some $55m of shares in the IPO but a bigger concern may be for the Australian Stock Exchange itself.
“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0